Weekly Clinical Updates

As infectious diseases such as SARS, Monkeypox, Polio, HIV, and Ebola travel the globe and garner media attention, Parasites Without Borders staff are curating resources in a timely, ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

MicrobeTV Fundraiser

Throughout November, December And January, All Donations Made To Parasites Without Borders Will Be Matched By PWB And Donated To MicrobeTV

MicrobeTV Podcast

MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.

June 15, 2023

Anemia as a risk factor for disease progression in patients admitted for COVID-19 | Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome | Post-COVID condition in patients with inflammatory rheumatic diseases | Persistent serum protein signatures define an inflammatory subcategory of long COVID | The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome | Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3 | Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza | Has COVID-19 Threatened Routine Childhood Vaccination? Insights From US Public Opinion Polls | Successful Treatment of Persistent Symptomatic Coronavirus Disease 19 (COVID-19) Infection with Extended Duration Nirmatrelvir/Ritonavir| Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT) | Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial | To Track Progress Toward Poliomyelitis Eradication — Worldwide, 2021–2022 | Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study

June 08,2023

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection | Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms | Long COVID Clinical Phenotypes Up to Six Months After Infection Identified by Latent Class Analysis of Self-Reported Symptoms | Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes | Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status | Smart Thermometer–Based Participatory Surveillance to Discern the Role of Children in Household Viral Transmission During the COVID-19 Pandemic | Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022 | National Trends in Anticoagulation Therapy for COVID-19 Hospitalized Adults in the United States: Analyses of the National COVID Cohort Collaborative | Coronary microvascular health in symptomatic patients with prior COVID-19 infection: an updated analysis

May 31,2023

Association between SARS-CoV-2 variants and frequency of acute symptoms: Analysis of a multi-institutional prospective cohort study - December 20, 2020 – June 20, 2022 | Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection | Pfizer’s PAXLOVID™ Receiving FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19 | Potential for Recurrent Mpox Outbreaks Among Gay, Bisexual, and Other Men Who Have Sex with Men — United States, 2023 | A Prospective Study of Key Correlates for Household Transmission of SARS-CoV-2 | Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19 (COVASP): a pragmatic, cluster-randomized, non-inferiority trial | COVID-19 and Risk for Mental Disorders Among Adults in Denmark

May 24, 2023

FDA voted in favor of approving the Abrysvo vaccine | Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years | Statement on the antigen composition of COVID-19 vaccines | Canine Olfactory Detection of SARS-CoV-2-Infected Humans | CDC HIV surveillance report

May 18, 2023

Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative | Trajectories of the evolution of post COVID-19 condition, up to two years after symptoms onset | Virus variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC. | COVID-19 mortality among selective serotonin reuptake inhibitor users - Results from a nationwide cohort | Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial

May 11, 2023

Impact of SARS-CoV-2 Variants on Inpatient Clinical Outcome | Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial | An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults | Targeted Vaccine Messaging to Promote COVID-19 Vaccines for Children and Youth | Vaccines and Related Biological Products Advisory Committee Meeting June 15, 2023 Announcement | Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study | COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration | Provisional Mortality Data | Prevalence of Post-Coronavirus Disease Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status

Situation Dashboards


World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information


World Health Organization (WHO)


Centers for Disease Control, US


International Society for Infectious Diseases


This Week in Virology (TWIV)

Receive updates about Parasites without Borders initiatives, developments, and learn more about parasites by subscribing to our periodic newsletter.

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top